Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:45 pm Sale |
2024-09-30 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 0 0.000% |
-3,703,433 (Position Closed) |
Filing History |
| 2024-05-21 4:49 pm Sale |
2024-05-18 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 0 0.000% |
-8,368,166 (Position Closed) |
Filing History |
| 2024-05-21 10:21 am Sale |
2024-05-20 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 0 0.000% |
-6,090,980 (Position Closed) |
Filing History |
| 2024-04-30 4:20 pm Purchase |
2024-04-10 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 8,368,166 12.800% |
7,292 (+0.09%) |
Filing History |
| 2024-04-29 6:08 pm Purchase |
2024-04-25 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 6,090,980 9.300% |
8,079 (+0.13%) |
Filing History |
| 2024-03-07 12:29 pm Sale |
2024-02-29 | 13G | Alpine Immune Sciences, Inc. ALPN |
BLACKROCK INC BLK |
3,026,330 4.600% |
-32,168 (-1.05%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
RA Capital Management, L.P. | 5,903,234 9.990% |
1,505,866 (+34.24%) |
Filing History |
| 2024-02-14 4:43 pm Sale |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund VI, L.P. | 0 0.000% |
-2,415,050 (Position Closed) |
Filing History |
| 2024-02-14 4:36 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
GREAT POINT PARTNERS LLC | 3,703,433 6.370% |
65,715 (+1.81%) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Paradigm BioCapital Advisors LP | 3,176,743 5.500% |
859,109 (+37.07%) |
Filing History |
| 2024-02-14 3:07 pm Sale |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Cormorant Asset Management LP | 2,550,000 4.390% |
-300,000 (-10.53%) |
Filing History |
| 2024-02-14 09:22 am Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Lynx1 Capital Management LP | 3,813,926 6.600% |
687,753 (+22.00%) |
Filing History |
| 2024-02-02 3:57 pm Purchase |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BLACKROCK INC BLK |
3,058,498 5.300% |
3,058,498 (New Position) |
Filing History |
| 2023-12-29 4:16 pm Sale |
2023-12-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 2,680,496 4.600% |
-1,546,347 (-36.58%) |
Filing History |
| 2023-11-22 10:25 am Purchase |
2023-11-20 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 6,082,901 9.800% |
2,918,793 (+92.25%) |
Filing History |
| 2023-11-14 4:16 pm Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
Decheng Capital China Life Sciences USD Fund III L.P. | 8,360,874 14.100% |
386,667 (+4.85%) |
Filing History |
| 2023-11-13 9:15 pm Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
Alpine ImmunoSciences L.P. | 4,266,215 7.200% |
360,625 (+9.23%) |
Filing History |
| 2023-11-13 08:51 am Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,226,843 7.300% |
145,251 (+3.56%) |
Filing History |
| 2023-10-23 4:02 pm Purchase |
2023-10-11 | 13G | Alpine Immune Sciences, Inc. ALPN |
Cormorant Asset Management LP | 2,850,000 5.790% |
2,850,000 (New Position) |
Filing History |
| 2023-02-14 4:58 pm Purchase |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Paradigm BioCapital Advisors LP | 2,317,634 5.050% |
102,912 (+4.65%) |
Filing History |